Not recruiting yet
Impact of Robotic Versus Endoscopic Surgery on Nipple Nerve Function Following Nipple-Sparing Mastectomy for Breast Cancer
NCT07850154 · Guangzhou Women and Children's Medical Center · Updated 30 Sept 2026
- What is being tested
- Robotic-assisted nipple-sparing mastectomy; Endoscopic-assisted nipple-sparing mastectomy
- For
- Breast Neoplasms
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages Not stated. About 374 people. The full rules are on the registry page.
- Where
- China
- When
- Starts or started 1 Oct 2026, ends 1 Oct 2031. Registered 30 Sept 2026.
- Results
- None posted yet.
In the researchers' words
This is a multicenter, prospective, randomized parallel controlled two arm clinical trial, designed to systematically evaluate impact of robotic versus endoscopic surgery on breast nerve function in patients undergoing nipple sparing mastectomy for breast cancer. The study will comprehensively assess the neurological functional outcomes, oncological safety, quality of life and sexual health, perioperative efficacy, surgical complications, and health economic value of the two minimally invasive approaches. This study has been approved by the Institutional Review Board of the Affiliated Women and Children's Medical Center of Guangzhou Medical University. Written informed consent will be obtained from all eligible participants prior to enrollment. All patient data will be anonymized and kept strictly confidential. Statistical analyses will be performed using SPSS 27.0 software, with a P value \< 0.05 set as the threshold for statistical significance.
Sites
- Guangzhou Women and Children's Medical Center, Guangzhou Medical UniversityGuangzhou, Guangdong, China
